menu search

Arvinas' potential in treating er+, her2- breast cancer

Arvinas focuses on protein degradation therapies, with current projects targeting breast and prostate cancers. Financially, ARVU holds robust liquidit...

September 4, 2023, 1:50 am

U.s. ipo weekly recap: august wraps up with 1 nano-cap

There was just one pricing this past week, which was excluded from our IPO stats, while holdover biotech ...

September 3, 2023, 10:45 am

Calliditas: q2 earnings de-risk this biotech play, 2024 expected to be inflection point

Calliditas Therapeutics downgrades Tarpeyo sales guidance due to slower-than-expected sales growth and market access challenges. Potential growth driv...

September 3, 2023, 4:26 am

3 beaten-down biotech stocks bound for a bounce back

biotech stocks soared high during the COVID-19 pandemic, as they were our only hope for new drugs and v...

September 2, 2023, 7:38 am

Cytomed therapeutics: an innovative immunology biotech company to watch

CytoMed Therapeutics is developing next-generation CAR-T cell therapies from γδ T cells for multiple solid tumor indications. The use of γδ T cell...

September 1, 2023, 8:00 pm

Immutep: nipping at the heels of lag3.is it impressive enough?

Immutep Limited is a small cap biotech focusing on the development of eftilagimod alpha, a novel molecu...

September 1, 2023, 6:57 pm

Why ginkgo bioworks stock was a 34% winner this week

The biotech announced not one, but two partnerships in the past few days. One was with a top name in th...

September 1, 2023, 6:50 pm

Pepgen announces presentations at the 2023 myotonic dystrophy foundation annual conference, ottawa neuromuscular disease meeting, and h.c. wainwright 25th annual global investment conference

BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonu...

September 1, 2023, 8:00 am

Arvinas to participate in upcoming investor conferences

NEW HAVEN, Conn., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...

September 1, 2023, 7:00 am

Puma biotechnology to present at the h.c. wainwright 25th annual global investment conference

LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach, CEO of Puma Biotechnology, will present a corporate update at the H.C. Wainwright Global Investment Confe...

August 31, 2023, 4:07 pm

Burning rock biotech limited (bnr) q2 2023 earnings call transcript

Burning Rock biotech Limited (NASDAQ:BNR ) Q2 2023 Earnings Conference Call August 31, 2023 8:00 AM ET ...

August 31, 2023, 3:12 pm

Galecto to present at investor conferences in september

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology fo...

August 31, 2023, 11:00 am

3 biotech stocks due for a massive short squeeze

Here's a look at 3 biotech short squeeze candidates. For investors looking for short-term gains, techni...

August 31, 2023, 10:33 am

Beam therapeutics to participate in upcoming september investor conferences

CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medic...

August 31, 2023, 10:30 am

Why is axcella health (axla) stock down 21% today?

Axcella Health (NASDAQ: AXLA ) stock is falling on Thursday following its announcement of a new Covid-19 treatment patent. However, it's not that thi...

August 31, 2023, 9:05 am

Is this the green light biotech stocks have been waiting for?

biotech stocks have underperformed the broad market since May, when the Federal Trade Commission moved ...

August 31, 2023, 7:53 am

The 3 most promising biotech stocks to own now

Despite polls showing most Americans are unhappy with the state of the economy, President Biden has defended his policies with claims he is improving ...

August 31, 2023, 5:42 am

Immuphama carries out fundraise ahead of key development period

ImmuPharma has raised £1.35 million through subscriptions for new equity that the biotech said will ...

August 31, 2023, 3:10 am

Adaptive biotechnologies to participate in the morgan stanley 21st annual global healthcare conference

SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage b...

August 30, 2023, 8:30 pm

Azure biotech announces educational initiative to create awareness of unmet women’s menopausal medical issue

Vulvovaginal Atrophy (VVA), also known as the Genitourinary Syndrome of Menopause (GSM), affects over 32 million women in the US. RIVER VALE, N.J., Au...

August 30, 2023, 4:55 pm


Search within

Pages Search Results: